3SBio company profile
Company profile
3SBio has 6,068 employees and is headquartered in Shenyang, China.
TPIAO, EPIAO, Yisaipu, Cipterbin and Mandi are the names people most associate with 3SBio Inc. Its biopharmaceutical portfolio addresses low platelet counts, anemia linked to chronic kidney disease, rheumatoid arthritis, psoriasis, breast cancer and hair loss. Beyond drug development and production, the group sells pharmaceuticals, operates pharmaceutical retail, and provides clinic, technology, agricultural and consulting services. Its activities reach the Chinese market, the United States and other countries.
In the fiscal year ended December 2025, 3SBio reported revenue of 17.7 billion yuan, up 94.3% from the previous year, and net profit of 8.5 billion yuan. The company had 6,068 employees and is headquartered in Shenyang, in the People's Republic of China, where it was founded in 1993.
Company facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Hong Kong SAR China
- Headquarters
- No. 3 A1, Road 10, Shenyang
- Employees
- 6,068
- Chief executive
- Jing Lou
- Founded
- 1993
- Fiscal year
- January - December
- Listing
- 1530 · HKEX
- Currency
- HKD
- ISIN
- KYG8875G1029
- Website
- 3sbio.com
3SBio and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| 3SBio1530 | Hong Kong SAR China | $4.56B | 6,068 | 60.3% | 3.90 |
| Akeso9926 | Hong Kong SAR China | $6.81B | 4,082 | -30.7% | — |
| Telix PharmaceuticalsTLX | Australia | $2.92B | 1,120 | 6.2% | 92.3 |
| InSilico Medicine Cayman TopCo3696 | Hong Kong SAR China | $2.59B | 333 | -6.9% | — |
| Genscript Biotech1548 | Hong Kong SAR China | $8.77B | 6,135 | 14.9% | — |
| Haisco Pharmaceutical Group002653 | China | $8.97B | 5,597 | 21.1% | 44.1 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
